Prescryptive Health
Prescryptive Health is a healthcare technology company that is transforming the U.S. pharmaceutical market by creating a more equitable and transparent ecosystem. Their platform empowers consumers to take ownership of their prescriptions through user-friendly technology, optimizing health outcomes and enhancing patient engagement. With a focus on real-time alerts and digital medicine cabinets, Prescryptive Health aims to improve adherence and reduce costs for patients, pharmacies, and employers. The company has demonstrated significant traction, processing over 13,000 cash prescriptions and partnering with various healthcare entities to enhance the prescription experience.
Prescryptive Health
Prescryptive Health is a healthcare technology company that is transforming the U.S. pharmaceutical market by creating a more equitable and transparent ecosystem. Their platform empowers consumers to take ownership of their prescriptions through user-friendly technology, optimizing health outcomes and enhancing patient engagement. With a focus on real-time alerts and digital medicine cabinets, Prescryptive Health aims to improve adherence and reduce costs for patients, pharmacies, and employers. The company has demonstrated significant traction, processing over 13,000 cash prescriptions and partnering with various healthcare entities to enhance the prescription experience.
TL;DR
Founded: 2017
Headquarters: Redmond, WA
Core product: myPrescryptive consumer pharmacy platform
Total disclosed funding: USD 26,000,000
Founders / leadership: Chris Blackley (Co‑Founder & CEO), Kevin Young (Co‑Founder & CPO)
Company Overview
Problem Domain
Prescription price transparency, medication adherence, pharmacy and PBM infrastructure.
Founded
2017
Industry
Healthcare technology / Digital health / Pharmacy infrastructure
Funding Track Record
USD 26,000,000
Participants included SeaChange Fund and Pallasite Ventures; Gerald Chan joined the board.
Investor Signal
“Raised a $26M Series A led by Morningside Ventures with participation from other healthcare investors.”